Astrikang Investment (China) Co., Ltd.

As a global biopharmaceutical company driven by innovation, Astrikon always believes that "science, stimulate infinite possibilities", and regard science as the top priority of all work.

We are a scientific -dominated global pharmaceutical company.We are committed to changing the future of medical care by releasing the power of science and benefiting humans, society and the earth.

Our strategy

We focus on developing truly innovative drugs and improving the accessibility of drugs.In this way, we bring the maximum benefits to global patients, medical systems and society.
We have formulated three major points to achieve growth through innovation strategies.

Science and Innovation

• Use a series of drug treatment methods to create the next generation of treatment, such as advanced biological agents, nucleotide therapy and cell therapy.
• State in terms of science, data and technology integration.
• Promote our pipeline.

Growth and treatment leadership

• Use our innovative science to create a more personalized, accurate and easy -to -obtain medical care experience.
• Participate in the entire healthcare ecosystem and establish a visible partnership to promote positive changes and results.
• Create the industry's leading growth in our treatment areas and regions.
• Continue to implement our 2025 operation plan.

People and Sustainable Development

• Continue to make Astraik an ideal workplace.
• Easily work in our group and achieve sustainable growth.
• Make sure we operate in the most intelligent way, and speed up the speed of providing medicines to patients through our future work plan.
• The use of scientific and innovative power has a positive impact on patients, healthcare systems and environment.
• Promote our sustainable development strategies through the three major comprehensive pillars: medical care, environmental protection, and morality and transparency.